Robert Veneziale
About Robert Veneziale
Robert Veneziale is a Senior Director of Toxicology at Bolt Biotherapeutics, Inc., with extensive experience in toxicology across various companies, including Schering-Plough, Pfizer, and Takeda. He holds a Ph.D. in Developmental Biology and Embryology and specializes in toxicology strategies for drug development programs.
Current Role at Bolt Biotherapeutics
Robert Veneziale serves as the Senior Director of Toxicology at Bolt Biotherapeutics, Inc. since 2024. In this role, he is responsible for designing and executing toxicology strategies specifically for immune-stimulating antibody conjugate (ISAC) drug development programs. He provides key scientific input on research activities and contributes to regulatory submissions. His position is based in Redwood City, California, and he operates in a remote capacity.
Previous Experience in Toxicology
Prior to his current role, Robert Veneziale held various positions in toxicology across multiple organizations. He worked at Takeda as a Research Fellow in Global Drug Safety Research & Evaluation from 2015 to 2021. He also served as Senior Director of Toxicology at Locanabio, Inc. from 2021 to 2023, and as Director of Toxicology at Halozyme Therapeutics, Inc. from 2012 to 2015. His earlier roles include positions at Pfizer Inc., Merck, and Schering-Plough Research Institute, where he specialized in reproductive toxicology and general toxicology.
Educational Background
Robert Veneziale earned his Doctor of Philosophy (Ph.D.) in Developmental Biology and Embryology from Jefferson Health, completing his studies from 1993 to 1998. He also holds a Bachelor of Science (BSc) in Biology from Delaware Valley University, where he studied from 1984 to 1988. His foundational education includes a high school diploma with a major in Small Animal Science from Saul W B Agricultural School, which he completed from 1980 to 1984.
Expertise in Drug Development
Robert Veneziale specializes in toxicology strategies for drug development, particularly in immune-stimulating antibody conjugate (ISAC) programs. He has expertise in handling various therapeutic modalities, including viral gene therapies and PEGylated proteins. His experience encompasses collaboration with external experts and participation in multi-disciplinary teams to resolve issues in drug development projects.
Professional History
Robert Veneziale's professional history includes significant roles in toxicology and research. He began his career as a Laboratory Assistant at Argus Research Laboratories and progressed to positions such as Associate Scientist/Supervisor at Rhone-Poulenc Rorer and Toxicologist at Schering-Plough Research Institute. His career spans over three decades, with a focus on toxicology and drug safety across various pharmaceutical companies.